CIK 0001041024 · Non-accelerated filer<br>Smaller reporting company
ROCKWELL MEDICAL, INC.
Sign in to watch- Ticker
- RMTI
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 383317208
- Phone
- 8004493353
- Business address
- 30142 WIXOM ROAD, WIXOM, MI, 48393
- Former names
- ROCKWELL MEDICAL TECHNOLOGIES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $8,420
- in 1 filing, $8K under 10b5-1 plans
Net −$8,420. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-01 | Strobeck Mark President and CEO | Sale 10b5-1 | −1,000 | $8.42 | $8K | 61,349 |
| 2026-07-01 | Strobeck Mark President and CEO | Grant or award | +30,000 | 62,349 | ||
| 2026-03-14 | Strobeck Mark President and CEO | Shares withheld for taxes | −7,333 | $0.90 | $7K | 323,493 |
| 2025-10-01 | Strobeck Mark President and CEO | Sale 10b5-1 | −6,926 | $1.19 | $8K | 330,826 |
| 2025-07-01 | Strobeck Mark President and CEO | Sale 10b5-1 | −6,926 | $0.82 | $6K | 337,752 |
| 2025-07-01 | Strobeck Mark President and CEO | Sale | −6,926 | $0.82 | $6K | 337,752 |
| 2025-05-20 | Strobeck Mark President and CEO | Grant or award · Performance-based restricted stock units | +352,000 | 352,000 | ||
| 2025-05-20 | Strobeck Mark President and CEO | Grant or award | +220,000 | 344,678 | ||
| 2025-05-20 | Strobeck Mark President and CEO | Grant or award · Stock Option (Right to Buy) | +308,000 | 308,000 | ||
| 2025-04-01 | Strobeck Mark President and CEO | Sale 10b5-1 | −6,926 | $1.08 | $7K | 124,678 |
| 2025-03-17 | Strobeck Mark President and CEO | Shares withheld for taxes | −6,101 | $1.77 | $11K | 131,604 |
| 2025-03-14 | Strobeck Mark President and CEO | Shares withheld for taxes | −7,333 | $1.70 | $12K | 137,705 |
| 2025-01-02 | Strobeck Mark President and CEO | Sale 10b5-1 | −2,163 | $2.06 | $4K | 145,038 |
| 2024-10-01 | Strobeck Mark President and CEO | Sale 10b5-1 | −2,163 | $3.69 | $8K | 147,201 |
| 2024-03-17 | Strobeck Mark President and CEO | Shares withheld for taxes | −6,101 | $1.40 | $9K | 149,364 |
| 2024-03-14 | Strobeck Mark President and CEO | Grant or award | +100,000 | 155,465 | ||
| 2024-03-14 | Strobeck Mark President and CEO | Grant or award · Stock Option (Right to Buy) | +141,560 | 141,560 | ||
| 2023-03-17 | Strobeck Mark President and CEO | Grant or award | +55,465 | 55,465 | ||
| 2023-03-17 | Strobeck Mark President and CEO | Grant or award · Stock Option (Right to Buy) | +77,105 | 77,105 | ||
| 2022-07-01 | Strobeck Mark President and CEO | Grant or award · Stock Option (Right to Buy) | +400,000 | 400,000 |
Page 1 of 1 · 20 trades